REVB Revelation Biosciences Inc. Forecast, Technical & Fundamental Analysis
Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini... Show more
REVB is expected to report earnings to rise 1.72% to -88 cents per share on November 05
Q3'26
Est.
$-0.88
Q2'26
Missed
by $0.04
Q4'25
Beat
by $8.25
Q3'25
Beat
by $7.83
Q2'25
Beat
by $1.99
The last earnings report on August 07 showed earnings per share of -87 cents, missing the estimate of -82 cents. With 136.03K shares outstanding, the current market capitalization sits at 3.98M.
A.I.dvisor indicates that over the last year, REVB has been closely correlated with INKT. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if REVB jumps, then INKT could also see price increases.
REVB in upward trend: price may jump up because it broke its lower Bollinger Band on August 20, 2026
REVB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 50 cases where REVB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
REVB moved above its 50-day moving average on August 17, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where REVB advanced for three days, in of 178 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 68 cases where REVB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on August 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on REVB as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for REVB turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where REVB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.396) is normal, around the industry mean (20.202). P/E Ratio (0.037) is within average values for comparable stocks, (22.945). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.854). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (443.091).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. REVB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. REVB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
